COMMUNIQUÉS West-GlobeNewswire

-
BioVie Inc. (OTCQB:BIVI) Attains Milestone
09/04/2018 -
Auris Medical Announces Early Repayment of Part of its Loan Facility
09/04/2018 -
PotNetwork Holding, Inc.'s Diamond CBD, Inc. to be featured at 2018 Telecom Review Summit held in Beirut, Lebanon.
09/04/2018 -
ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board
09/04/2018 -
RavenQuest Common Shares Listed on OTC now DTC Eligible
09/04/2018 -
Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness
09/04/2018 -
Transactions under Novozymes’ stock buyback program
09/04/2018 -
MPI - Oncology Venture exercises option to inlicense Dovitinib a Phase 3 Multi Tyrosine Kinase Inhibitor
09/04/2018 -
Solon Eiendom ASA : Strategic equity investment by Union - and subsequent offering
09/04/2018 -
Solon Eiendom ASA : KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
09/04/2018 -
RECORDATI ACQUIRES INTERNATIONAL RIGHTS TO CYSTAGON® FROM MYLAN
09/04/2018 -
Shire plc : Rule 2.9 Announcement
09/04/2018 -
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Canada by Avir Pharma
09/04/2018 -
INNATE PHARMA : Upcoming investor conferences
09/04/2018 -
INNATE PHARMA : Prochains rendez-vous investisseurs
09/04/2018 -
argenx appoints Keith Woods as Chief Operating Officer
09/04/2018 -
Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader
09/04/2018 -
AveXis Enters Agreement to be Acquired by Novartis AG for $8.7 billion
09/04/2018 -
Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis
09/04/2018
Pages